FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W68282923> ?p ?o ?g. }

• W68282923 endingPage "165" @default.
• W68282923 startingPage "161" @default.
• W68282923 abstract "Monoclonal antibodies that block the high-affinity interleukin-2 receptor expressed on alloantigen-reactive T lymphocytes may cause selective immunosuppression. Daclizumab is a genetically engineered human IgG1 monoclonal antibody that binds specifically to the alpha chain of the interleukin-2 receptor and may thus reduce the risk of rejection after renal transplantation.We administered daclizumab (1.0 mg per kilogram of body weight) or placebo intravenously before transplantation and once every other week afterward, for a total of five doses, to 260 patients receiving first cadaveric kidney grafts and immunosuppressive therapy with cyclosporine, azathioprine, and prednisone. The patients were followed at regular intervals for 12 months. The primary end point was the incidence of biopsy-confirmed acute rejection within six months after transplantation.Of the 126 patients given daclizumab, 28 (22 percent) had biopsy-confirmed episodes of acute rejection, as compared with 47 of the 134 patients (35 percent) who received placebo (P=0.03). Graft survival at 12 months was 95 percent in the daclizumab-treated patients, as compared with 90 percent in the patients given placebo (P=0.08). The patients given daclizumab did not have any adverse reactions to the drug, and at six months, there were no significant differences between the two groups with respect to infectious complications or cancers. The serum half-life of daclizumab was 20 days, and its administration resulted in prolonged saturation of interleukin-2alpha receptors on circulating lymphocytes.Daclizumab reduces the frequency of acute rejection in kidney-transplant recipients." @default.
• W68282923 created "2016-06-24" @default.
• W68282923 creator A5001224240 @default.
• W68282923 creator A5007122777 @default.
• W68282923 creator A5017078172 @default.
• W68282923 creator A5017765749 @default.
• W68282923 creator A5021921889 @default.
• W68282923 creator A5026789430 @default.
• W68282923 creator A5042236941 @default.
• W68282923 creator A5045536800 @default.
• W68282923 creator A5051550363 @default.
• W68282923 creator A5068487647 @default.
• W68282923 creator A5077662405 @default.
• W68282923 creator A5089118254 @default.
• W68282923 date "1998-01-15" @default.
• W68282923 modified "2023-10-16" @default.
• W68282923 title "Interleukin-2–Receptor Blockade with Daclizumab to Prevent Acute Rejection in Renal Transplantation" @default.
• W68282923 cites W1934038313 @default.
• W68282923 cites W1964210645 @default.
• W68282923 cites W1996431651 @default.
• W68282923 cites W2000988825 @default.
• W68282923 cites W2006336823 @default.
• W68282923 cites W2019306593 @default.
• W68282923 cites W2042336731 @default.
• W68282923 cites W2052150715 @default.
• W68282923 cites W2060516601 @default.
• W68282923 cites W2071112640 @default.
• W68282923 cites W2071648784 @default.
• W68282923 cites W2076597593 @default.
• W68282923 cites W2165929916 @default.
• W68282923 cites W2280027108 @default.
• W68282923 cites W2332754031 @default.
• W68282923 cites W50336179 @default.
• W68282923 doi "https://doi.org/10.1056/nejm199801153380304" @default.
• W68282923 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/9428817" @default.
• W68282923 hasPublicationYear "1998" @default.
• W68282923 type Work @default.
• W68282923 sameAs 68282923 @default.
• W68282923 citedByCount "847" @default.
• W68282923 countsByYear W682829232012 @default.
• W68282923 countsByYear W682829232013 @default.
• W68282923 countsByYear W682829232014 @default.
• W68282923 countsByYear W682829232015 @default.
• W68282923 countsByYear W682829232016 @default.
• W68282923 countsByYear W682829232017 @default.
• W68282923 countsByYear W682829232018 @default.
• W68282923 countsByYear W682829232019 @default.
• W68282923 countsByYear W682829232020 @default.
• W68282923 countsByYear W682829232021 @default.
• W68282923 countsByYear W682829232022 @default.
• W68282923 countsByYear W682829232023 @default.
• W68282923 crossrefType "journal-article" @default.
• W68282923 hasAuthorship W68282923A5001224240 @default.
• W68282923 hasAuthorship W68282923A5007122777 @default.
• W68282923 hasAuthorship W68282923A5017078172 @default.
• W68282923 hasAuthorship W68282923A5017765749 @default.
• W68282923 hasAuthorship W68282923A5021921889 @default.
• W68282923 hasAuthorship W68282923A5026789430 @default.
• W68282923 hasAuthorship W68282923A5042236941 @default.
• W68282923 hasAuthorship W68282923A5045536800 @default.
• W68282923 hasAuthorship W68282923A5051550363 @default.
• W68282923 hasAuthorship W68282923A5068487647 @default.
• W68282923 hasAuthorship W68282923A5077662405 @default.
• W68282923 hasAuthorship W68282923A5089118254 @default.
• W68282923 hasBestOaLocation W682829231 @default.
• W68282923 hasConcept C126322002 @default.
• W68282923 hasConcept C126894567 @default.
• W68282923 hasConcept C142724271 @default.
• W68282923 hasConcept C204787440 @default.
• W68282923 hasConcept C27081682 @default.
• W68282923 hasConcept C2776760755 @default.
• W68282923 hasConcept C2779134260 @default.
• W68282923 hasConcept C2779719350 @default.
• W68282923 hasConcept C2780252810 @default.
• W68282923 hasConcept C2780303639 @default.
• W68282923 hasConcept C2909675724 @default.
• W68282923 hasConcept C2911091166 @default.
• W68282923 hasConcept C71924100 @default.
• W68282923 hasConcept C90924648 @default.
• W68282923 hasConceptScore W68282923C126322002 @default.
• W68282923 hasConceptScore W68282923C126894567 @default.
• W68282923 hasConceptScore W68282923C142724271 @default.
• W68282923 hasConceptScore W68282923C204787440 @default.
• W68282923 hasConceptScore W68282923C27081682 @default.
• W68282923 hasConceptScore W68282923C2776760755 @default.
• W68282923 hasConceptScore W68282923C2779134260 @default.
• W68282923 hasConceptScore W68282923C2779719350 @default.
• W68282923 hasConceptScore W68282923C2780252810 @default.
• W68282923 hasConceptScore W68282923C2780303639 @default.
• W68282923 hasConceptScore W68282923C2909675724 @default.
• W68282923 hasConceptScore W68282923C2911091166 @default.
• W68282923 hasConceptScore W68282923C71924100 @default.
• W68282923 hasConceptScore W68282923C90924648 @default.
• W68282923 hasIssue "3" @default.
• W68282923 hasLocation W682829231 @default.
• W68282923 hasLocation W682829232 @default.
• W68282923 hasOpenAccess W68282923 @default.
• W68282923 hasPrimaryLocation W682829231 @default.

• next